- Home
- CMMB vs ORKT Comparison
CMMB vs ORKT Comparison
Compare CMMB & ORKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- ORKT
- Stock Information
- Founded
- CMMB 2004
- ORKT 2003
- Country
- CMMB Israel
- ORKT Singapore
- Employees
- CMMB N/A
- ORKT N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- ORKT
- Sector
- CMMB Health Care
- ORKT
- Exchange
- CMMB Nasdaq
- ORKT NYSE
- Market Cap
- CMMB 32.2M
- ORKT 34.7M
- IPO Year
- CMMB N/A
- ORKT 2024
- Fundamental
- Price
- CMMB $1.71
- ORKT $1.10
- Analyst Decision
- CMMB Strong Buy
- ORKT Strong Buy
- Analyst Count
- CMMB 2
- ORKT 1
- Target Price
- CMMB $9.00
- ORKT $5.00
- AVG Volume (30 Days)
- CMMB 835.3K
- ORKT 5.4M
- Earning Date
- CMMB 03-06-2025
- ORKT 10-16-2024
- Dividend Yield
- CMMB N/A
- ORKT N/A
- EPS Growth
- CMMB N/A
- ORKT N/A
- EPS
- CMMB N/A
- ORKT N/A
- Revenue
- CMMB N/A
- ORKT $3,904,592.00
- Revenue This Year
- CMMB N/A
- ORKT N/A
- Revenue Next Year
- CMMB N/A
- ORKT $39.99
- P/E Ratio
- CMMB N/A
- ORKT N/A
- Revenue Growth
- CMMB N/A
- ORKT N/A
- 52 Week Low
- CMMB $0.58
- ORKT $0.62
- 52 Week High
- CMMB $2.55
- ORKT $8.00
- Technical
- Relative Strength Index (RSI)
- CMMB 32.89
- ORKT N/A
- Support Level
- CMMB $1.66
- ORKT N/A
- Resistance Level
- CMMB $2.06
- ORKT N/A
- Average True Range (ATR)
- CMMB 0.16
- ORKT 0.00
- MACD
- CMMB -0.04
- ORKT 0.00
- Stochastic Oscillator
- CMMB 9.43
- ORKT 0.00
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About ORKT ORANGEKLOUD TECHNOLOGY INC
Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.